This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
The new ECO grade is made using renewable feedstock
Lack of technology transfer stands out as a formidable barrier
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
The inspection classification was determined by the agency as Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated
